Shuyan Li

Aug 20, 2024 | bmccancer.biomedcentral.com | Wei-xiang Qi |Shuyan Li |Huan Li |Jiayi Chen |Shengguang Zhao

The study was designed as a prospective cohort from four prospective trials (NCT NCT04435197, NCT04435197, NCT04513418, NCT03990532) [24,25,26], and all included patients were treated with NCRT with or without pembrolizumab followed by esophagectomy and reconstructed the conduit with a narrow gastric tube intrathoracic or cervical anastomosis at Ruijin Hospital, Shanghai Jiao Tong university school of medicine, between Jan 2019 and July 2023.

Aug 16, 2023 | nature.com | Shuyan Li

AbstractNon-small cell lung cancer (NSCLC) is the most common type of lung cancer, with high morbidity and mortality worldwide. Although the dysregulation of BARX1 expression has been shown to be associated with malignant cancers, including NSCLC, the underlying mechanism remains elusive. In this study, we identified BARX1 as a common differentially expressed gene in lung squamous cell carcinoma and adenocarcinoma.